CN Stock MarketDetailed Quotes

Wanbangde Pharmaceutical Holding Group (002082)

Watchlist
  • 28.49
  • 0.000.00%
Market Closed Apr 30 09:30 CST
17.43BMarket Cap-219.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Wanbangde Pharmaceutical Holding Group (002082) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
medical apparatus466.97M41.79%
化学原料药及制剂259.76M23.25%
Other commodities199.24M17.83%
Traditional Chinese medicine191.36M17.13%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Professional equipment manufacturing and service466.97M41.79%
Pharmaceutical manufacturing451.12M40.37%
Pharmaceutical circulation198.06M17.73%
Other1.18M0.11%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory785.48M70.30%
Overseas331.85M29.70%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -